News for Viracta Therapeutics, Inc. (VIRX)

Summary On July 2, 2025, Nasdaq Inc (NDAQ) announced the delisting of several securities from its stock market. The delisted securities include those of Advance

NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the American Depositary Shares of Advanced Health Intelligence Ltd. Advanced Health Intelligence Ltd.’s security was suspended on July 30, 2024 and has not traded on Nasdaq since that time.

**media[533489]**

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.77%

Editor’s note: This story has been corrected to state that Castellum Inc — not Constellium SE — announced the pricing of a public stock offering. With U....

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

U.S. stock futures tumbled on Friday in premarket hours after a mixed Thursday. All four index futures slipped in trade.

With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows: Constellium SE CSTM announc...

SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on the treatment a

**media[501085]**

Shares of Marvell Technology, Inc. MRVL rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter financial resul...

**media[464653]**

This week, once again, companies across the biotech sector continued to re-evaluate their pipelines and trim their workforces in a bid to conserve cash and extend their financial runway.

- Reported combined Stage 1 and Stage 2 results from the relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL) cohort of the Phase...

XOMA is entitled to a mid-single digit royalty on global OJEMDA™ sales First and only FDA-approved type II RAF inhibitor for patients with relapsed or...

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

WAVE Life Sciences Ltd. (WVE), a preclinical biopharmaceutical company, has seen a significant increase in its stock price over the past three months. The compa

Viracta Therapeutics Appoints Darrel P. Cohen, M.D., Ph.D. as Chief Medical Officer